Results 1 to 10 of about 184,844 (205)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Background Evidence suggests differences in clinical characteristics, causes, and prognoses between heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).
Tin‐Kwang Lin +6 more
doaj +3 more sources
Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure [PDF]
Zhongguo quanke yixue, 2022 The American Heart Association (AHA) , American College of Cardiology (ACC) and Heart Failure Society of America (HFSA) jointly released the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (hereinafter referred to as the 2022 Guideline) .
Yifang GUO
doaj +1 more source
Advanced heart failure with reduced ejection fraction [PDF]
Baylor University Medical Center Proceedings, 2020 Patients suffering advanced heart failure with reduced ejection fraction (HFrEF) account for a large portion of patients admitted to hospitals worldwide. Mortality and 30-day readmission rates for HFrEF are now a focus of value-based payment models, making management of this disease a priority for hospitals, physicians, and payers alike.
Albert Hicks +5 more
openaire +2 more sources
Clinics and Practice, 2023 Heart failure and mental health conditions frequently coexist and have a negative impact on health-related quality of life and prognosis. We aimed to evaluate depression and anxiety symptoms and to determine the association between psychological distress
Timea Magdolna Szabo +6 more
doaj +1 more source
Metabolomics and a Breath Sensor Identify Acetone as a Biomarker for Heart Failure
Biomolecules, 2022 Background: Multi-omics delivers more biological insight than targeted investigations. We applied multi-omics to patients with heart failure with reduced ejection fraction (HFrEF).
Patrick A. Gladding +15 more
doaj +1 more source
ESC Heart Failure, 2023 Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF]
Mayu Tochiya +11 more
doaj +1 more source
Vericiguat for Heart Failure with Reduced Ejection Fraction [PDF]
Current Cardiology Reports, 2021 AbstractPurpose of ReviewThe nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway plays an important role in the regulation of cardiovascular function, and it is disrupted in heart failure (HF), resulting in decreased protection against myocardial injury.
Lombardi C. M. +11 more
openaire +4 more sources
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
Frontiers in Cardiovascular Medicine, 2021 This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu +8 more
doaj +1 more source
Chronic heart failure with reduced ejection fraction [PDF]
Canadian Medical Association Journal, 2014 See also page [510][1] and [www.cmaj.ca/lookup/doi/10.1503/cmaj.131742][2] Heart failure with reduced ejection fraction is a clinical syndrome of dyspnea, exercise intolerance and/or edema resulting from an impairment of ejection of blood, usually documented by a left ventricular ejection ...
Yasbanoo, Moayedi, Jeremy, Kobulnik
openaire +2 more sources
Biomolecules, 2022 Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the heart that gradually result in reduced cardiac output (HFrEF) and/or increased cardiac pressures at rest and under stress (HFpEF).
Federico Ferro +3 more
doaj +1 more source